Ankur D Shah, Afzal Ariff, Cara J Sammartino, Christina A Raker, Susie L Hu
{"title":"Scaling Peritoneal Dialysis: Center Effects Thresholds in US Facilities.","authors":"Ankur D Shah, Afzal Ariff, Cara J Sammartino, Christina A Raker, Susie L Hu","doi":"10.34067/KID.0000000969","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Center effects in peritoneal dialysis (PD) refer to how facility patient volume impacts outcomes, with larger centers typically demonstrating better patient results. Recent U.S. policy changes have promoted PD utilization, but it remains unclear how this growth has affected center-level thresholds associated with improved outcomes. This study aimed to characterize facility-level changes in PD patient volume threshold across the United States.</p><p><strong>Methods: </strong>We conducted a retrospective observational study analyzing PD utilization across U.S. dialysis facilities from 2010-2021 using the CMS Dialysis Facility Compare database. The final analytic cohort included 8,982 unique facilities. We used mixed-effects logistic regression models with random facility effects to examine temporal trends in facilities meeting key PD volume thresholds (>0, >20, and >50 patients), adjusting for region, facility size, and profit status.</p><p><strong>Results: </strong>From 2010 to 2021, facilities with active PD services rose from 38.4% to 44.6%. The proportion of PD-offering facilities with large programs (>20 patients) increased from 22.9% to 29%, while those with very large programs (>50 patients) nearly doubled from 3.5% to 5.9%. In adjusted analyses, facilities in 2021 had significantly higher odds of maintaining programs with >20 patients (OR 6.08, 95% CI 4.82-7.68) and >50 patients (OR 8.65, 95% CI 5.34-13.99) compared to 2010. Significant regional variation persisted, with Western facilities consistently maintaining larger PD programs than other regions.</p><p><strong>Conclusions: </strong>While the United States has seen meaningful growth in facilities with large PD programs likely to achieve center effects thresholds, opportunities remain to expand PD access more broadly. Current policies have successfully encouraged some facilities to expand PD programs, but additional interventions may be needed to achieve more widespread adoption and address regional disparities.</p>","PeriodicalId":17882,"journal":{"name":"Kidney360","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney360","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34067/KID.0000000969","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Center effects in peritoneal dialysis (PD) refer to how facility patient volume impacts outcomes, with larger centers typically demonstrating better patient results. Recent U.S. policy changes have promoted PD utilization, but it remains unclear how this growth has affected center-level thresholds associated with improved outcomes. This study aimed to characterize facility-level changes in PD patient volume threshold across the United States.
Methods: We conducted a retrospective observational study analyzing PD utilization across U.S. dialysis facilities from 2010-2021 using the CMS Dialysis Facility Compare database. The final analytic cohort included 8,982 unique facilities. We used mixed-effects logistic regression models with random facility effects to examine temporal trends in facilities meeting key PD volume thresholds (>0, >20, and >50 patients), adjusting for region, facility size, and profit status.
Results: From 2010 to 2021, facilities with active PD services rose from 38.4% to 44.6%. The proportion of PD-offering facilities with large programs (>20 patients) increased from 22.9% to 29%, while those with very large programs (>50 patients) nearly doubled from 3.5% to 5.9%. In adjusted analyses, facilities in 2021 had significantly higher odds of maintaining programs with >20 patients (OR 6.08, 95% CI 4.82-7.68) and >50 patients (OR 8.65, 95% CI 5.34-13.99) compared to 2010. Significant regional variation persisted, with Western facilities consistently maintaining larger PD programs than other regions.
Conclusions: While the United States has seen meaningful growth in facilities with large PD programs likely to achieve center effects thresholds, opportunities remain to expand PD access more broadly. Current policies have successfully encouraged some facilities to expand PD programs, but additional interventions may be needed to achieve more widespread adoption and address regional disparities.
背景:腹膜透析(PD)的中心效应是指设施患者数量如何影响结果,较大的中心通常显示更好的患者结果。最近美国政策的变化促进了PD的使用,但目前尚不清楚这种增长如何影响与改善结果相关的中心水平阈值。本研究旨在描述美国PD患者体积阈值的设施水平变化。方法:我们使用CMS透析设施比较数据库进行了一项回顾性观察性研究,分析了2010-2021年美国透析设施的PD使用情况。最终的分析队列包括8,982个独特的设施。我们使用随机设施效应的混合效应逻辑回归模型来检验满足关键PD容量阈值的设施的时间趋势(>0,>20和>50患者),调整区域,设施规模和利润状况。结果:从2010年到2021年,活跃PD服务的设施从38.4%上升到44.6%。拥有大型项目(20名患者)的pd提供机构的比例从22.9%增加到29%,而拥有超大型项目(50名患者)的pd提供机构的比例几乎翻了一番,从3.5%增加到5.9%。在调整分析中,与2010年相比,2021年的医疗机构维持>20例患者(OR 6.08, 95% CI 4.82-7.68)和>50例患者(OR 8.65, 95% CI 5.34-13.99)的项目的几率明显更高。显著的区域差异持续存在,西方设施始终保持比其他地区更大的PD计划。结论:虽然美国的大型PD项目有可能达到中心效应阈值,但仍有机会扩大PD的使用范围。目前的政策已经成功地鼓励了一些机构扩大PD项目,但可能需要额外的干预措施来实现更广泛的采用并解决地区差异。